WHITEHOUSE STATION, N.J., April 30 (UPI) -- Merck Research Laboratories says the U.S. Food and Drug Administration has rejected an application for a new cholesterol drug.
... -chain fatty acids were shown to reduce intestinal inflammation. Interestingly, also reducing cholesterol by the systemic inhibition of HMG-CoA with pravastatin has been shown to reduce inflammation ...
High blood pressure and high cholesterol levels appear to be risk factors for retinal vein occlusion, a condition that causes vision loss, according to a report in the May issue of Archives of ...
... blood pressure), diabetes and hyperlipidemia (high cholesterol).
Of patients with retinal vein occlusion, 63. ... vs. 16.7 percent), and those with high cholesterol levels had an approximately 2.5-fold ...
... State University electrical engineering researcher had developed "smart" bandages, able to gauge cholesterol, insulin and blood chemistry without needles. The technology could also triple life ...
Managing your cholesterol may also help you manage your prostate- specific antigen level. ... the relationship between low-density lipoprotein (LDL) cholesterol and PSA prior to beginning statin therapy.
... & Co. has halted a study of an experimental drug it had touted as key to energizing its sagging cholesterol franchise, barely three weeks after U.S. regulators refused to allow sales of the drug....
... from incorporating into vesicles.
Although ezetimibe can dramatically decrease blood cholesterol concentrations in some people, it is barely effective in others, the researchers said.
“ Therefore,” ...
... of IHD is not clear, in part because of other factors related to low HDL cholesterol levels, such as plasma triglycerides, which may contribute independently to increases in cardiovascular events. "… ...
... this vitamin helps maintain adequate HDL-cholesterol levels in the blood and thus lower the risk of ... another major pathway known as "Reverse Cholesterol Transport." Therefore, it maintains HDL levels ...
... new study sheds light on the action of the drug ezetimibe (trade name Zetia), which is used to treat high cholesterol. Ezetimibe is unique among cholesterol-lowering drugs in that it works by cutting ...
... in the blood to fat tissue for storage. Excess amounts of these compounds -- cholesterol and triglycerides -- in the bloodstream can be dangerous, leading to heart disease and increased risk of ...
... The alternatively spliced form, on the other hand, is more resistant to statin inhibition of cholesterol production.
Researchers found that the "alternative splicing" also accounted for 15 percent ...
... in the gene and see whether they were more prevalent in people who also had elevated cholesterol, abnormal blood glucose or the other components of the metabolic syndrome," says first author Latisha ...
Researchers have discovered an unknown regulator of fat and
cholesterol production in the liver of mice, a significant finding that
could eventually lead to new therapies for lowering unhealthy blood ...
